Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
General Mills, Inc. stock logo
GIS
General Mills
$34.44
+3.3%
$34.08
$31.75
$54.18
$17.79B-0.039.89 million shs12.43 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,110.37
+0.8%
$1,022.46
$623.78
$1,182.73
$1.04T0.533.11 million shs3.31 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
General Mills, Inc. stock logo
GIS
General Mills
+3.23%+0.08%+2.17%-4.70%-35.63%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
+0.61%-1.08%+4.10%+21.26%+44.17%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
General Mills, Inc. stock logo
GIS
General Mills
$34.44
+3.3%
$34.08
$31.75
$54.18
$17.79B-0.039.89 million shs12.43 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,110.37
+0.8%
$1,022.46
$623.78
$1,182.73
$1.04T0.533.11 million shs3.31 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
General Mills, Inc. stock logo
GIS
General Mills
+3.23%+0.08%+2.17%-4.70%-35.63%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
+0.61%-1.08%+4.10%+21.26%+44.17%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
General Mills, Inc. stock logo
GIS
General Mills
1.86
Reduce$39.3914.37% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.87
Moderate Buy$1,230.8910.85% Upside

Current Analyst Ratings Breakdown

Latest GIS and LLY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/22/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOverweight
6/22/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetHold$1,050.00 ➝ $1,135.00
6/16/2026
General Mills, Inc. stock logo
GIS
General Mills
Reiterated RatingSell (D)
6/15/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOutperform
6/9/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetBuy$1,330.00 ➝ $1,350.00
6/8/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOutperform
6/5/2026
General Mills, Inc. stock logo
GIS
General Mills
Lower Price TargetUnderweight$37.00 ➝ $32.00
6/5/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOverweight
6/3/2026
General Mills, Inc. stock logo
GIS
General Mills
DowngradeMarket PerformUnderperform$31.00
6/3/2026
General Mills, Inc. stock logo
GIS
General Mills
Lower Price TargetUnderweight$36.00 ➝ $31.00
6/2/2026
General Mills, Inc. stock logo
GIS
General Mills
Reiterated RatingNeutral$36.00
(Data available from 6/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
General Mills, Inc. stock logo
GIS
General Mills
$19.49B0.94$5.49 per share6.27$16.98 per share2.03
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$65.18B16.04$25.33 per share43.84$28.07 per share39.56
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
General Mills, Inc. stock logo
GIS
General Mills
$2.30B$4.098.4210.83N/A12.05%19.19%5.48%7/1/2026 (Confirmed)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$20.64B$28.1539.4424.901.2034.98%105.77%23.76%8/5/2026 (Estimated)

Latest GIS and LLY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/1/2026Q4 2026
General Mills, Inc. stock logo
GIS
General Mills
$0.82N/AN/AN/A$4.59 billionN/A
4/30/2026Q1 2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.97$8.55+$1.58$8.26$17.82 billion$19.80 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
General Mills, Inc. stock logo
GIS
General Mills
$2.447.08%+4.13%59.66%5 Years
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.920.62%+15.18%24.58%11 Years

Latest GIS and LLY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/22/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.730.63%8/14/20268/14/20269/10/2026
5/4/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.730.69%5/15/20265/15/20266/10/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
General Mills, Inc. stock logo
GIS
General Mills
1.17
0.56
0.36
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.26
1.50
1.10

Institutional Ownership

CompanyInstitutional Ownership
General Mills, Inc. stock logo
GIS
General Mills
75.71%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%

Insider Ownership

CompanyInsider Ownership
General Mills, Inc. stock logo
GIS
General Mills
0.30%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.14%
CompanyEmployeesShares OutstandingFree FloatOptionable
General Mills, Inc. stock logo
GIS
General Mills
33,000533.68 million532.08 millionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
50,000941.74 million940.42 millionOptionable

Recent News About These Companies

Biotech's Silent Resurgence (5-Year Base Breakout)
Lilly Drug Access Draws Attention
How Eli Lilly's CEO Plans to Defeat Pharma's Boom-Bust Cycle
Nvidia Targets a $300 Billion Pharma Market
Sector Update: Healthcare Stocks Advance in Afternoon Trading
The $50B Plan Merck Stock Was Broadcasting
How Eli Lilly Became a $1 Trillion Company

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
General Mills stock logo

General Mills NYSE:GIS

$34.44 +1.10 (+3.30%)
Closing price 06/23/2026 03:58 PM Eastern
Extended Trading
$34.57 +0.13 (+0.39%)
As of 06/23/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

General Mills, Inc. manufactures and markets branded consumer foods worldwide. The company operates through four segments: North America Retail; International; Pet; and North America Foodservice. It offers grain, ready-to-eat cereals, refrigerated yogurt, soup, meal kits, refrigerated and frozen dough products, dessert and baking mixes, bakery flour, frozen pizza and pizza snacks, snack bars, fruit and savory snacks, ice cream and frozen desserts, unbaked and fully baked frozen dough products, frozen hot snacks, ethnic meals, side dish mixes, frozen breakfast and entrees, nutrition bars, and frozen and shelf-stable vegetables. The company also manufactures and markets pet food products, including dog and cat food; and operates ice cream parlors. It markets its products under the Annie's, Betty Crocker, Bisquick, Blue Buffalo, Bugles, Cascadian Farm, Cheerios, Chex, Cinnamon Toast Crunch, Cocoa Puffs, Cookie Crisp, Dunkaroos, Edgard & Cooper, Fiber One, Fruit by the Foot, Fruit Gushers, Fruit Roll-Ups, Gardetto's, Gold Medal, Golden Grahams, Häagen-Dazs, Kitano, Kix, Lärabar, Latina, Lucky Charms, Muir Glen, Nature Valley, Nudges, Oatmeal Crisp, Old El Paso, Pillsbury, Progresso, Tastefuls, Total, Totino's , Trix, True Chews, True Solutions, Wanchai Ferry, Wheaties, Wilderness, and Yoki brands. The company sells its products to grocery stores, mass merchandisers, membership stores, natural food chains, drug, dollar and discount chains, e-commerce retailers, commercial and noncommercial foodservice distributors and operators, restaurants, convenience stores, and pet specialty stores. General Mills, Inc. was founded in 1866 and is headquartered in Minneapolis, Minnesota.

Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$1,110.37 +8.29 (+0.75%)
Closing price 06/23/2026 03:58 PM Eastern
Extended Trading
$1,106.79 -3.58 (-0.32%)
As of 06/23/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.